Matching-adjusted indirect comparison of enzalutamide versus darolutamide doublet in mHSPC
Sign Up to like & getrecommendations! Published in 2025 at "Future Oncology"
DOI: 10.1080/14796694.2025.2526324
Abstract: ABSTRACT Aims To compare the efficacy of enzalutamide + androgen-deprivation therapy (ADT) versus darolutamide + ADT for treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC) using a matching-adjusted indirect comparison (MAIC). Patients and methods Individual patient data from… read more here.
Keywords: matching adjusted; indirect comparison; darolutamide adt; adjusted indirect ... See more keywords